Vanda Pharmaceuticals, Inc. (VNDA)
6.385
-1.06
(-14.18%)
USD |
NASDAQ |
May 07, 15:45
Vanda Pharmaceuticals SG&A Expense (TTM) : 237.95M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Eli Lilly & Co. | 11.56B |
| AnaptysBio, Inc. | 50.74M |
| Gossamer Bio, Inc. | 37.63M |
| BridgeBio Pharma, Inc. | 531.22M |
| Arcellx, Inc. | 117.76M |